Compare Eli Lilly And Co (LLY) vs ProShares Ultra Semiconductors (USD) Price & Performance

Eli Lilly And CoTrade

ProShares Ultra SemiconductorsTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs ProShares Ultra Semiconductors — how do they compare? Eli Lilly And Co trades at $1,147.06 (market cap $1.02T), while ProShares Ultra Semiconductors trades at $90.53. The key difference: Eli Lilly And Co pays a 0.6% dividend while ProShares Ultra Semiconductors pays none. Which is the better fit depends on your goals.

	LLY	USD
Market Cap	$1.02T	—
Sector	Health	Leveraged / Inverse
52-Week High	$1.24K	$113.53
52-Week Low	$625.65	$39.58
Enterprise Value	$1.06T	—
Dividend Yield	0.6%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

No Aura AI signal available yet.

ProShares Ultra Semiconductors

USD trades at $83.24, up 1.19% with bearish technical signals from moving averages. Key support lies at $80 with resistance at $85. The company announced a $0.14 dividend for H1-2026, payable June 30, 2026. Recent news highlights include coverage of semiconductor sector volatility and earnings from various firms, though specific financials for USD are not detailed in the provided data.

The outlook remains cautious due to bearish technical indicators and limited fundamental data. Investment opportunity hinges on upcoming financial disclosures and sector performance, while risks include market volatility and reliance on broader economic conditions affecting semiconductor and related industries.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 3 hours agoBullish Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.Proactive Investors · 8 hours agoBearish Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 12 hours agoBearish View details →

USD

View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About ProShares Ultra Semiconductors

USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.